Potthoff K, Uhlig J, Jacobasch L, Muller L, et al. Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VA Int J Cancer 2025 Sep 9. doi: 10.1002/ijc.70139.
PMID: 40923598